MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · IEX Real-Time Price · USD

42.25

-0.18 (-0.42%)

At close: Apr 25, 2024, 4:00 PM

42.28

+0.03 (0.07%)

Pre-market: Apr 26, 2024, 8:02 AM EDT

MLTX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-44.08	-64.51	-53.64	-0.09
Depreciation & Amortization	0.01	0.01	0	0
Share-Based Compensation	7.11	9.65	13.9	0
Other Operating Activities	-5.82	-1.05	4.56	-0.23
Operating Cash Flow	-42.78	-55.89	-35.18	-0.32
Capital Expenditures	-0.28	-0.02	-0.05	0
Change in Investments	-24.9	-32.32	0	-115
Investing Cash Flow	-25.18	-32.34	-0.05	-115
Share Issuance / Repurchase	482.45	0.05	0.1	117
Debt Issued / Paid	0	-15	15	0
Other Financing Activities	-2.75	134.65	28.16	-0.35
Financing Cash Flow	479.7	119.69	43.26	116.65
Exchange Rate Effect	-0.08	0.01	0	0
Net Cash Flow	411.66	31.47	8.04	1.34
Free Cash Flow	-43.06	-55.91	-35.23	-0.32
Free Cash Flow Per Share	-0.88	-1.90	-0.15	-0.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).